Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

R Thomas

Showing results (731-740 of 5,435) with videos related to

Pageof 544
Sort By:
Dermatologic Clinics|October 1, 1989
Cancer of the perioral regionJ B Goslen, J R Thomas
Endocrinology|October 5, 2017
Do Environmental Chemicals Make Us Fat?R Thomas Zoeller, Jerrold J Heindel
Vascular Pharmacology|June 9, 2016
Clinical significance of residual platelet reactivity in patients treated with platelet P2Y12 inhibitorsMark R Thomas, Robert F Storey
Journal of Dental Research|July 1, 1977
The role of calcitonin in the calcification of ental matrixL W Kline, N R Thomas
Biochemical Pharmacology|May 15, 1989
[3H]-BRL 43694 (Granisetron), a specific ligand for 5-HT3 binding sites in rat brain cortical membranesD R Nelson, D R Thomas
Journal of Colloid and Interface Science|November 18, 2005
Group contribution method for the estimation of contact angle trends on modified polymer surfacesRichard R Thomas, Lori E Stephans
International Journal of Cancer|December 29, 2005
Animal models for the study of squamous cell carcinoma of the upper aerodigestive tract: a historical perspective with review of their utility and limitations. Part A. Chemically-induced de novo cancer, syngeneic animal models of HNSCC, animal models of transplanted xenogeneic human tumorsLee P Smith, Giovana R Thomas
International Journal of Cancer|December 29, 2005
Animal models for the study of squamous cell carcinoma of the upper aerodigestive tract: a historical perspective with review of their utility and limitations part B. Transgenic mouse modelsGiovana R Thomas, Lee P Smith
Advances in Wound Care : the Journal for Prevention and Healing|November 18, 1997
Using principal component analysis to describe wound statusA A Bartolucci, D R Thomas
Platelets|June 5, 2015
The future of P2Y12 receptor antagonistsMark R Thomas, Robert F Storey
Pageof 544

Showing results (731-740 of 5,435) with videos related to

Sort By:
Pageof 544
Dermatologic Clinics|October 1, 1989
Cancer of the perioral regionJ B Goslen, J R Thomas
Endocrinology|October 5, 2017
Do Environmental Chemicals Make Us Fat?R Thomas Zoeller, Jerrold J Heindel
Vascular Pharmacology|June 9, 2016
Clinical significance of residual platelet reactivity in patients treated with platelet P2Y12 inhibitorsMark R Thomas, Robert F Storey
Journal of Dental Research|July 1, 1977
The role of calcitonin in the calcification of ental matrixL W Kline, N R Thomas
Biochemical Pharmacology|May 15, 1989
[3H]-BRL 43694 (Granisetron), a specific ligand for 5-HT3 binding sites in rat brain cortical membranesD R Nelson, D R Thomas
Journal of Colloid and Interface Science|November 18, 2005
Group contribution method for the estimation of contact angle trends on modified polymer surfacesRichard R Thomas, Lori E Stephans
International Journal of Cancer|December 29, 2005
Animal models for the study of squamous cell carcinoma of the upper aerodigestive tract: a historical perspective with review of their utility and limitations. Part A. Chemically-induced de novo cancer, syngeneic animal models of HNSCC, animal models of transplanted xenogeneic human tumorsLee P Smith, Giovana R Thomas
International Journal of Cancer|December 29, 2005
Animal models for the study of squamous cell carcinoma of the upper aerodigestive tract: a historical perspective with review of their utility and limitations part B. Transgenic mouse modelsGiovana R Thomas, Lee P Smith
Advances in Wound Care : the Journal for Prevention and Healing|November 18, 1997
Using principal component analysis to describe wound statusA A Bartolucci, D R Thomas
Platelets|June 5, 2015
The future of P2Y12 receptor antagonistsMark R Thomas, Robert F Storey
Pageof 544